You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Vital funding for Maxion autoimmune disease research

Maxion Therapeutics has announced that it has been awarded a £2m grant from Innovate UK. The financing represents part of its Biomedical Catalyst 2022 Round 2: Industry-led R&D funding competition.